Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

PRECIGEN, INC. Director's Dealing 2020

Apr 2, 2020

32044_dirs_2020-04-02_d78e51e4-0850-4752-a36f-20e970f85d4f.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: PRECIGEN, INC. (PGEN)
CIK: 0001356090
Period of Report: 2020-03-31

Reporting Person: Sabzevari Helen (President and CEO)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2020-03-31 Common Stock M 14340 Acquired 112342 Direct
2020-04-01 Common Stock S 5450 $3.0119 Disposed 106892 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2020-03-31 Restricted Stock Units $ M 14340 Disposed Common Stock (14340) Direct

Footnotes

F1: Each restricted stock unit represents a contingent right to receive one share of Precigen common stock.

F2: This sale was effected pursuant to the terms of a 10b5-1 plan adopted by the reporting person and was made in order to pay the tax liability arising from the vesting of restricted stock units.

F3: The restricted stock units were granted on April 9, 2019 and have vested in full.